Toward a sustainable cord blood supply in the United States
The U.S. government began a federal cord blood program in 2005 to help create a nationwide inventory of high-quality and genetically diverse units of cord blood. However, the proportion of cord blood stem cell transplants relative to transplants using other types of stem cells - such as those from bone marrow - has been falling in recent years. Because of declining demand and increasing costs, some of the 19 public banks, which are nonprofit entities, have been struggling to make ends meet.
After more than 15 years of supporting the national cord blood system, the U.S. Department of Health and Human Services asked the RAND Corporation to evaluate the economics of the system and what could be done to improve its sustainability. Kandice Kapinos, lead researcher on the study, reviews the results in this free Share the Science webinar.
Attend to learn some of the key research findings, including:
- How the national program has affected the publicly available inventory
- What current trends could mean for the future of the cord blood industry
- The value of cord blood transplantation for certain populations
- The overall value vs cost of the public bank system
Complete the form to view the recorded webcast!
About Share the Science
Share the Science is a free webinar series designed to bring you powerful presentations by the top experts in cellular therapy. Generously supported by WellSky and Save the Cord Foundation, Share the Science webinars connect you to the world's most innovative and influential scientists, clinical researchers, and experts as they highlight the latest breakthroughs and most promising developments in cellular therapy.